Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice
- PMID: 38368306
- DOI: 10.1007/s15010-024-02185-1
Utilizing metagenomic next-generation sequencing for pathogen detection and diagnosis in lower respiratory tract infections in real-world clinical practice
Abstract
Background: Infectious etiologies of lower respiratory tract infections (LRTIs) by the conventional microbiology tests (CMTs) can be challenging. Metagenomic next-generation sequencing (mNGS) has great potential in clinical use for its comprehensiveness in identifying pathogens, particularly those difficult-to-culture organisms.
Methods: We analyzed a total of 205 clinical samples from 201 patients with suspected LRTIs using mNGS in parallel with CMTs. mNGS results were used to guide treatment adjustments for patients who had negative CMT results. The efficacy of treatment was subsequently evaluated in these patients.
Results: mNGS-detected microorganisms in 91.7% (188/205) of the clinical samples, whereas CMTs demonstrated a lower detection rate, identifying microorganisms in only 37.6% (77/205) of samples. Compared to CMT results, mNGS exhibited a detection sensitivity of 93.5% and 95.4% in all 205 clinical samples and 180 bronchoalveolar lavage fluid (BALF) samples, respectively. A total of 114 patients (114/201; 56.7%) showed negative CMT results, among which 92 received treatment adjustments guided by their positive mNGS results. Notably, 67.4% (62/92) of patients demonstrated effective treatment, while 25% (23/92) experienced a stabilized condition. Subgroup analysis of cancer patients revealed that 41.9% (13/31) exhibited an effective response to treatment, and 35.5% (11/31) maintained a stable condition following medication adjustments guided by mNGS.
Conclusion: mNGS demonstrated great potential in identifying microorganisms of clinical significance in LRTIs. The rapid turnaround time and reduced susceptibility to the impact of antimicrobial administration make mNGS a valuable supplementary tool for diagnosis and treatment decision-making for suspected LRTIs in clinical practice.
Keywords: Conventional microbiology test; Diagnosis; Lower respiratory tract infection; Metagenomic next-generation sequencing.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
A single-center, retrospective study of hospitalized patients with lower respiratory tract infections: clinical assessment of metagenomic next-generation sequencing and identification of risk factors in patients.Respir Res. 2024 Jun 20;25(1):250. doi: 10.1186/s12931-024-02887-y. Respir Res. 2024. PMID: 38902783 Free PMC article.
-
Clinical utility of metagenomic next-generation sequencing in pathogen detection for lower respiratory tract infections.Sci Rep. 2025 May 30;15(1):19039. doi: 10.1038/s41598-025-03564-w. Sci Rep. 2025. PMID: 40447717 Free PMC article.
-
The clinical significance of in-house metagenomic next-generation sequencing for bronchoalveolar lavage fluid diagnostics in patients with lower respiratory tract infections.Front Cell Infect Microbiol. 2022 Dec 15;12:961746. doi: 10.3389/fcimb.2022.961746. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36590589 Free PMC article.
-
Metagenomic next generation sequencing of bronchoalveolar lavage fluids for the identification of pathogens in patients with pulmonary infection: A retrospective study.Diagn Microbiol Infect Dis. 2024 Sep;110(1):116402. doi: 10.1016/j.diagmicrobio.2024.116402. Epub 2024 Jun 12. Diagn Microbiol Infect Dis. 2024. PMID: 38878340 Review.
-
Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections.J Adv Res. 2021 Sep 29;38:201-212. doi: 10.1016/j.jare.2021.09.012. eCollection 2022 May. J Adv Res. 2021. PMID: 35572406 Free PMC article. Review.
Cited by
-
Comparative Analysis of Metagenomic Next-Generation Sequencing, Sanger Sequencing, and Conventional Culture for Detecting Common Pathogens Causing Lower Respiratory Tract Infections in Clinical Samples.Microorganisms. 2025 Mar 18;13(3):682. doi: 10.3390/microorganisms13030682. Microorganisms. 2025. PMID: 40142572 Free PMC article.
-
Pathogen Detection in Spinal Infections: Next-Generation Sequencing Versus Conventional Microbiological Methods.Curr Med Sci. 2025 Apr;45(2):331-340. doi: 10.1007/s11596-025-00040-4. Epub 2025 Mar 26. Curr Med Sci. 2025. PMID: 40138143
-
Analysis of the characteristics of mixed infections with Mycoplasma pneumoniae in children.Sci Rep. 2025 Mar 19;15(1):9414. doi: 10.1038/s41598-025-94292-8. Sci Rep. 2025. PMID: 40108415 Free PMC article.
-
Case report: co-infection of Scedosporium and Mycobacterium in lungs.AME Case Rep. 2024 Oct 17;9:3. doi: 10.21037/acr-24-9. eCollection 2025. AME Case Rep. 2024. PMID: 39866262 Free PMC article.
-
Antimicrobial strategies of lower respiratory tract infections in immunocompromised patients based on metagenomic next-generation sequencing: a retrospective study.BMC Infect Dis. 2025 Mar 14;25(1):360. doi: 10.1186/s12879-025-10753-5. BMC Infect Dis. 2025. PMID: 40087607 Free PMC article.
References
-
- Collaborators GL. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17:1133–61. - DOI
-
- Wei Gu SM, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol Mech Dis. 2019;14:319–38. - DOI
MeSH terms
LinkOut - more resources
Full Text Sources